Internet Searching May Get ‘Riskier’ For Patients After FDA Citations
This article was originally published in The Pink Sheet Daily
“Sponsored searches” need to contain risk information, agency tells 14 firms in letters covering 48 products.
You may also be interested in...
Office of Prescription Drug Promotion issued just six letters citing companies for improper drug promotion in 2020, including the placement of safety information in an email and making unfounded COVID-19 claims. New research projects focus on celebrity endorsements, medical conference materials.
New review process planned to launch next year. FDA officials and industry reps note re-emergence of FDA enforcement actions targeting internet-sponsored links.
Office of Prescription Drug Promotion is focused on most egregious issues where human safety is at stake; CDER's Woodcock also says that First Amendment issues are affecting enforcement.